See more : Dispensa Group Plc (DISP.L) Income Statement Analysis – Financial Results
Complete financial analysis of Asep Medical Holdings Inc (ASEP.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Asep Medical Holdings Inc, a leading company in the Biotechnology industry within the Healthcare sector.
- Koppers Holdings Inc. (KOP) Income Statement Analysis – Financial Results
- Fremont Gold Ltd. (FRE.V) Income Statement Analysis – Financial Results
- Wildpack Beverage Inc. (WLDPF) Income Statement Analysis – Financial Results
- POTENS (7712.TWO) Income Statement Analysis – Financial Results
- EasTower Wireless Inc. (ETWLF) Income Statement Analysis – Financial Results
Asep Medical Holdings Inc (ASEP.CN)
About Asep Medical Holdings Inc
Asep Medical Holdings Inc., through its subsidiary, ASEP Medical Inc. focuses on developing an early diagnostic tool for Sepsis and peptide therapeutic treatments for multiple applications. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to Asep Medical Holdings Inc. Asep Medical Holdings Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 21.14K | 0.00 | 0.00 | 0.00 | 61.17K |
| Cost of Revenue | 134.88K | 155.40K | 177.18K | 26.45K | 55.01K |
| Gross Profit | -113.74K | -155.40K | -177.18K | -26.45K | 6.16K |
| Gross Profit Ratio | -538.03% | 0.00% | 0.00% | 0.00% | 10.07% |
| Research & Development | 678.54K | 615.04K | 73.60K | 0.00 | 0.00 |
| General & Administrative | 4.23M | 2.54M | 1.73M | 1.65K | 6.51K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.23M | 2.54M | 1.73M | 1.65K | 6.51K |
| Other Expenses | 2.70M | 2.28M | 177.18K | 0.00 | 0.00 |
| Operating Expenses | 7.74M | 5.44M | 1.98M | 1.65K | 6.51K |
| Cost & Expenses | 7.74M | 5.44M | 1.98M | 28.10K | 61.53K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 270.00 | 814.00 | 102.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.29M | 1.28M | 177.18K | 28.10K | 353.00 |
| EBITDA | -8.14M | -4.56M | -2.06M | 0.00 | 0.00 |
| EBITDA Ratio | -38,486.19% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.72M | -5.44M | -1.98M | -28.10K | -353.00 |
| Operating Income Ratio | -36,524.42% | 0.00% | 0.00% | 0.00% | -0.58% |
| Total Other Income/Expenses | -1.71M | -403.73K | -289.55K | 0.00 | 0.00 |
| Income Before Tax | -9.43M | -5.85M | -2.34M | -28.10K | -353.00 |
| Income Before Tax Ratio | -44,609.81% | 0.00% | 0.00% | 0.00% | -0.58% |
| Income Tax Expense | 0.00 | -89.10K | -41.48K | 0.00 | 0.00 |
| Net Income | -8.23M | -5.76M | -2.30M | -28.10K | -353.00 |
| Net Income Ratio | -38,918.30% | 0.00% | 0.00% | 0.00% | -0.58% |
| EPS | -0.13 | -0.10 | -0.04 | 0.00 | 0.00 |
| EPS Diluted | -0.13 | -0.10 | -0.04 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 62.24M | 56.20M | 56.13M | 14.91M | 14.91M |
| Weighted Avg Shares Out (Dil) | 62.24M | 56.20M | 56.13M | 14.91M | 14.91M |
Source: https://incomestatements.info
Category: Stock Reports